Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.10.0.1
Condensed Consolidated Balance Sheets - USD ($)
Jun. 30, 2018
Dec. 31, 2017
Current Assets:    
Cash $ 23,996,609 $ 185,151
Accounts receivable and other receivables, net 275,931 227,918
Inventory, net 181,859 247,466
Prepaid expenses and other current assets 234,695 108,352
Total Current Assets 24,689,094 768,887
Property and equipment, net 334,525 376,920
Intangible assets, net 101,009 106,167
Deferred public offering costs 1,367,730
Other assets 1,053,402 67,309
Total Assets 26,178,030 2,687,013
Current Liabilities:    
Accounts payable 1,591,068 4,228,073
Accrued expenses 2,400,822 23,135,344
Accrued issuable equity 2,347,469 2,939,906
Derivative liabilities 51,405 3,448,390
Current portion of convertible notes payable 50,000
Convertible notes payable - related party 747,567
Notes payable 337,966 597,966
Current portion of deferred revenue 377,715 383,771
Total Current Liabilities 7,106,445 35,531,017
Convertible notes payable, non-current portion, net of debt discount of $0 and $499,435 as of June 30, 2018 and December 31, 2017, respectively 3,200,096
Deferred revenue, non-current portion 23,044 50,283
Total Liabilities 7,129,489 38,781,396
Series B Convertible Preferred Stock, 10,000 shares designated, 0 and 8,250 issued and outstanding as of June 30, 2018 and December 31, 2017, respectively 825,000
Commitments and contingencies
Stockholders' Equity (Deficiency):    
Common stock, $0.001 par value, 500,000,000 shares authorized, 24,699,131 and 5,523,673 shares issued and outstanding as of June 30, 2018 and December 31, 2017, respectively 24,699 5,524
Additional paid-in capital 174,487,809 119,499,141
Accumulated deficit (155,463,975) (156,435,278)
Total Stockholders' Equity (Deficiency) 19,048,541 (36,919,383)
Total Liabilities and Stockholders' Equity (Deficiency) 26,178,030 2,687,013
Series A Convertible Preferred Stock [Member]    
Stockholders' Equity (Deficiency):    
Preferred stock, $0.001 par value, 40,000,000 shares authorized; 11,000
Series C Convertible Preferred Stock [Member]    
Stockholders' Equity (Deficiency):    
Preferred stock, $0.001 par value, 40,000,000 shares authorized; 230
Series D Convertible Preferred Stock [Member]    
Stockholders' Equity (Deficiency):    
Preferred stock, $0.001 par value, 40,000,000 shares authorized; $ 8